{"id":39150,"date":"2017-05-18T06:39:47","date_gmt":"2017-05-18T10:39:47","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=39150"},"modified":"2017-05-18T06:27:50","modified_gmt":"2017-05-18T10:27:50","slug":"a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150","title":{"rendered":"A Close Scrutiny At A $293 Million Deal Between DURECT Corporation (NASDAQ:DRRX) And Sandoz AG Makes Major Revelations"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>DURECT Corporation (NASDAQ:DRRX) <\/strong>and Sandoz AG recently came together in a joint move to sign into a progressive commercialization\u00a0and development\u00a0deal for the U.S. for POSIMIR.<\/p>\n<p style=\"text-align: justify;\">As a matter of fact, POSIMIR is DURECT Corp.&#8217;s\u00a0&#8220;locally acting, non-opioid analgesic targeted at providing up to three days of continuous pain relief after a patient undergoes surgery.&#8221;<\/p>\n<p style=\"text-align: justify;\">According to a number of the top trusted sources, DURECT went ahead to actually announce Sandoz would move ahead to make an agreed upon upfront payment to DUREC which amounts to about $20 million. The underlying existing potential stands at about an additional $43 million that is associated with the various regulatory as well as the development milestones.<\/p>\n<p style=\"text-align: justify;\">The company\u2019s insiders indicate that a pair of analysts did a remarkable task lauding the Sandoz deal. The healthcare research analyst with Laidlaw &amp; Company, Francois Briseboisis while talking to news reporters said, &#8220;we see the deal as relatively heavily front loaded and are encouraged by this large pharma validation. Sandoz&#8217;s market presence and resources could truly benefit DRRX and help them take market share from <strong>Pacira Pharmaceuticals Inc <\/strong>(<strong>NASDAQ:PCRX).\u201d<\/strong><\/p>\n<p style=\"text-align: justify;\">Some of the top executives working with the provider have lately been quite vocal especially on matters to do with carrying out the heavy lifting to move the company a notch higher in terms of attaining great business success.<\/p>\n<p style=\"text-align: justify;\">There is this word moving about in the company that DRRX&#8217;s favorable terms\u00a0might have culminated from PCRX&#8217;s strong FY2017 guidance and there is this outlook at the partnership as a great non-dilutive funding event.<\/p>\n<p style=\"text-align: justify;\">One fact that is coming out pretty clearly is the idea that DRRX since the early times has insisted on the great need to spark a series of negotiations that would see to it that a number of potential partners are brought on board to help hasten the business success it has always looked forward to.<\/p>\n<p style=\"text-align: justify;\">One thing that is for sure is that Sandoz moves in with a great promise of impressive expertise as well as a vibrant hospital presence and leveraging on that would spell out great gain on the part of the provider.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>DURECT Corporation (NASDAQ:DRRX) and Sandoz AG recently came together in a joint move to sign into a progressive commercialization\u00a0and development\u00a0deal for the U.S. for POSIMIR. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":39159,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[10728,10727,10729,5698,12656,5697],"stock_ticker":[],"class_list":["post-39150","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-durect-corporation","tag-durect-corporation-nasdaqdrrx","tag-nasdaqdrrx","tag-nasdaqpcrx","tag-pacira-pharmaceuticals-inc","tag-pacira-pharmaceuticals-inc-nasdaqpcrx","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>A Close Scrutiny At A $293 Million Deal Between DURECT Corporation (NASDAQ:DRRX) And Sandoz AG Makes Major Revelations - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A Close Scrutiny At A $293 Million Deal Between DURECT Corporation (NASDAQ:DRRX) And Sandoz AG Makes Major Revelations - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"DURECT Corporation (NASDAQ:DRRX) and Sandoz AG recently came together in a joint move to sign into a progressive commercialization\u00a0and development\u00a0deal for the U.S. for POSIMIR. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-05-18T10:39:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39158-images__4_.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"308\" \/>\n\t<meta property=\"og:image:height\" content=\"164\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"A Close Scrutiny At A $293 Million Deal Between DURECT Corporation (NASDAQ:DRRX) And Sandoz AG Makes Major Revelations\",\"datePublished\":\"2017-05-18T10:39:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150\"},\"wordCount\":375,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39158-images__4_.jpeg\",\"keywords\":[\"DURECT Corporation\",\"DURECT Corporation (NASDAQ:DRRX)\",\"NASDAQ:DRRX\",\"NASDAQ:PCRX\",\"Pacira Pharmaceuticals Inc\",\"Pacira Pharmaceuticals Inc. (NASDAQ:PCRX)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150\",\"name\":\"A Close Scrutiny At A $293 Million Deal Between DURECT Corporation (NASDAQ:DRRX) And Sandoz AG Makes Major Revelations - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39158-images__4_.jpeg\",\"datePublished\":\"2017-05-18T10:39:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39158-images__4_.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39158-images__4_.jpeg\",\"width\":308,\"height\":164},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A Close Scrutiny At A $293 Million Deal Between DURECT Corporation (NASDAQ:DRRX) And Sandoz AG Makes Major Revelations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A Close Scrutiny At A $293 Million Deal Between DURECT Corporation (NASDAQ:DRRX) And Sandoz AG Makes Major Revelations - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150","og_locale":"en_US","og_type":"article","og_title":"A Close Scrutiny At A $293 Million Deal Between DURECT Corporation (NASDAQ:DRRX) And Sandoz AG Makes Major Revelations - Wall Street PR","og_description":"DURECT Corporation (NASDAQ:DRRX) and Sandoz AG recently came together in a joint move to sign into a progressive commercialization\u00a0and development\u00a0deal for the U.S. for POSIMIR. [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-05-18T10:39:47+00:00","og_image":[{"width":308,"height":164,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39158-images__4_.jpeg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"A Close Scrutiny At A $293 Million Deal Between DURECT Corporation (NASDAQ:DRRX) And Sandoz AG Makes Major Revelations","datePublished":"2017-05-18T10:39:47+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150"},"wordCount":375,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39158-images__4_.jpeg","keywords":["DURECT Corporation","DURECT Corporation (NASDAQ:DRRX)","NASDAQ:DRRX","NASDAQ:PCRX","Pacira Pharmaceuticals Inc","Pacira Pharmaceuticals Inc. (NASDAQ:PCRX)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150","url":"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150","name":"A Close Scrutiny At A $293 Million Deal Between DURECT Corporation (NASDAQ:DRRX) And Sandoz AG Makes Major Revelations - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39158-images__4_.jpeg","datePublished":"2017-05-18T10:39:47+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39158-images__4_.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39158-images__4_.jpeg","width":308,"height":164},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/a-close-scrutiny-at-a-293-million-deal-between-durect-corporation-nasdaqdrrx-and-sandoz-ag-makes-major-revelations-39150#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"A Close Scrutiny At A $293 Million Deal Between DURECT Corporation (NASDAQ:DRRX) And Sandoz AG Makes Major Revelations"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/39150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=39150"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/39150\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/39159"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=39150"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=39150"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=39150"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=39150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}